| Jefferson Internal Medicine Associates, Ltd | |
|
1111 S Jefferson St Suite B Roanoke VA 24016-4724 | |
| (540) 342-1007 | |
| (540) 345-4643 |
| Full Name | Jefferson Internal Medicine Associates, Ltd |
|---|---|
| Speciality | Internal Medicine |
| Location | 1111 S Jefferson St, Roanoke, Virginia |
| Authorized Official Name and Position | Sarah B Carroll (PRACTICE MANAGER) |
| Authorized Official Contact | 5403421007 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jefferson Internal Medicine Associates, Ltd 1111 S Jefferson St Suite B Roanoke VA 24016-4724 Ph: (540) 342-1007 | Jefferson Internal Medicine Associates, Ltd 1111 S Jefferson St Suite B Roanoke VA 24016-4724 Ph: (540) 342-1007 |
| NPI Number | 1053302703 |
|---|---|
| Provider Enumeration Date | 11/02/2005 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 8426064619 |
|---|---|
| Medicare Enrollment ID | O20060227000252 |
News Archive
AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
A two-day Royal Society meeting held this week in London - which examined "whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists" - "brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public," the Washington Post reports.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.
Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053302703 | NPI | - | NPPES |
| 072204 | Other | ANTHEM | |
| 3374958 | Other | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Michael Alan Malpass |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659379675 PECOS PAC ID: 8729036488 Enrollment ID: I20060119000286 |
News Archive
AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
A two-day Royal Society meeting held this week in London - which examined "whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists" - "brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public," the Washington Post reports.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.
Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.
› Verified 3 days ago
| Provider Name | Adel M Salama |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003807496 PECOS PAC ID: 2163438219 Enrollment ID: I20100603000535 |
News Archive
AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
A two-day Royal Society meeting held this week in London - which examined "whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists" - "brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public," the Washington Post reports.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.
Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.
› Verified 3 days ago
News Archive
AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides.
A two-day Royal Society meeting held this week in London - which examined "whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists" - "brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public," the Washington Post reports.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.
Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.
› Verified 3 days ago
Valley Gericare Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2917 Penn Forest Blvd, Ste 518, Roanoke, VA 24018 Phone: 540-989-3613 | |
The Center For Ultra Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4235 Colonial Ave, First Floor, Roanoke, VA 24018 Phone: 540-312-5595 | |
Roanoke Partners In Health, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3239 Electric Rd, Suite A, Roanoke, VA 24018 Phone: 540-904-7912 Fax: 540-904-7926 | |
Carilion Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 213 S Jefferson St, Suite 625, Roanoke, VA 24011 Phone: 540-224-5681 | |
Hiren B Parikh, Md Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3338 Circle Brook Dr, Roanoke, VA 24018 Phone: 609-781-8818 | |
Premier Telehealth Solutions Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6701 Peters Creek Rd Ste 110, Roanoke, VA 24019 Phone: 800-765-7130 Fax: 888-500-1891 |